TSXV:PCLO - Post Discussion
Post by
Betteryear2 on Jun 29, 2023 8:41am
PharmaCielo Provides Corporate Update
- PharmaCielo is actively working with more than 24 customers in 15 countries globally, with a focus on psychoactive APIs and dried flower.
- The Company recently made its first shipment of THC Distillate and THC-Dominant Dried Flower to a customer in Australia that will be supplying these products to dispensaries across the country.
- The Company has closed the final tranche of the previously announced non-brokered private placement and announced its plans to issue up to 5,000 debenture units in a new non-brokered private placement for aggregate gross proceeds of up to $5,000,000.
- The Company also announced that it has agreed to issue shares in settlement of debenture interest payments.
All amounts expressed in Canadian dollars unless otherwise noted
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - June 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today provided shareholders with an update on several ongoing initiatives.
PharmaCielo Provides Corporate Update (newsfilecorp.com)
Be the first to comment on this post